loading
Schlusskurs vom Vortag:
$2.63
Offen:
$2.61
24-Stunden-Volumen:
136.90K
Relative Volume:
0.71
Marktkapitalisierung:
$15.49M
Einnahmen:
$14.58M
Nettoeinkommen (Verlust:
$-12.57M
KGV:
-0.4542
EPS:
-5.68
Netto-Cashflow:
$-13.07M
1W Leistung:
-18.91%
1M Leistung:
-25.22%
6M Leistung:
+6.79%
1J Leistung:
-23.34%
1-Tages-Spanne:
Value
$2.38
$2.74
1-Wochen-Bereich:
Value
$2.38
$3.36
52-Wochen-Spanne:
Value
$1.91
$6.28

Vivos Therapeutics Inc Stock (VVOS) Company Profile

Name
Firmenname
Vivos Therapeutics Inc
Name
Telefon
(866)908-4867
Name
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
VVOS's Discussions on Twitter

Vergleichen Sie VVOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
VVOS
Vivos Therapeutics Inc
2.58 15.49M 14.58M -12.57M -13.07M -5.68
Medical Devices icon
ABT
Abbott Laboratories
131.70 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.76 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
375.31 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.69 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.11 42.10B 5.72B 4.17B 259.90M 6.97

Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten

pulisher
07:57 AM

Vivos Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

07:57 AM
pulisher
Apr 01, 2025

Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Vivos Therapeutics (VVOS) Grows Revenue by 26% and Cuts Operatin - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Vivos Therapeutics Reports Revenue Growth and Strategic Shift - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Vivos Therapeutics Q4 2024 revenue rises 9% By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Vivos Earnings: Revenue Jumps 9% as FDA Approves Game-Changing Pediatric Sleep Apnea Treatment - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Decline in Short Interest - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Medical Device Innovator Vivos Sets Key Earnings Date: What to Watch in 2024 Results - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

Analyzing Vivos Therapeutics (NASDAQ:VVOS) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

The Silent Epidemic: How Women With Obstructive Sleep Apnea (OSA) Are Often Misdiagnosed - Yahoo Finance

Mar 26, 2025
pulisher
Mar 20, 2025

Vivos Therapeutics (VVOS) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update - Defense World

Mar 20, 2025
pulisher
Mar 11, 2025

Vivos Drives Innovation in Chronic Pain Care with Non-Invasive Treatment for Sleep Apnea - PRWeb

Mar 11, 2025
pulisher
Feb 27, 2025

Anti-Snoring Devices Markets: Oral Appliances, Nasal - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Anti-Snoring Devices Markets: Oral Appliances, Nasal Devices, Position Control DevicesGlobal Forecast to 2029 with ResMed, SomnoMed, ProSomnus, and Vivos Therapeutics, and DynaFlex Dominating - Yahoo Finance UK

Feb 27, 2025
pulisher
Feb 26, 2025

Comparing Vivos Therapeutics (NASDAQ:VVOS) and Regenicin (OTCMKTS:RGIN) - Armenian Reporter

Feb 26, 2025
pulisher
Feb 26, 2025

Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center - MarketScreener

Feb 26, 2025
pulisher
Feb 25, 2025

Vivos Explores ‘Outright Acquisitions of Sleep Centers’ - Sleep Review

Feb 25, 2025
pulisher
Feb 24, 2025

Vivos Therapeutics sees strong adoption of OSA treatment, expands strategic alliance - Proactive Investors UK

Feb 24, 2025
pulisher
Feb 24, 2025

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and - EIN News

Feb 24, 2025
pulisher
Feb 20, 2025

Reviewing Vivos Therapeutics (NASDAQ:VVOS) & Biostage (OTCMKTS:BSTG) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

Vivos Therapeutics Inc to Host Earnings Call - ACCESS Newswire

Feb 19, 2025
pulisher
Feb 18, 2025

Vivos Therapeutics to participate in Fireside Chat with Water Tower Research - Proactive Investors UK

Feb 18, 2025
pulisher
Feb 18, 2025

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm - EIN News

Feb 18, 2025
pulisher
Feb 18, 2025

Revolutionary Sleep Apnea Treatment: Vivos CEO Reveals Market Strategy and Medical Partnerships - Stock Titan

Feb 18, 2025
pulisher
Feb 16, 2025

Investors Give Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares A 30% Hiding - Simply Wall St

Feb 16, 2025
pulisher
Feb 16, 2025

Vivos Therapeutics Enters Into At The Market Offering Agreement with H.C. Wainwright & Co., LLC**Littleton, Colo. – Vivos Therapeutics, Inc. (NASDAQ: VVOS) announced on February 14, 2025, that the company has entered into an At The Market Offering - Defense World

Feb 16, 2025
pulisher
Feb 15, 2025

Vivos Therapeutics Enters Market Offering Agreement with Wainwright - TipRanks

Feb 15, 2025
pulisher
Feb 12, 2025

Vivos Therapeutics announces up to $50M mixed shelf offering - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Vivos Therapeutics Inc Files For Mixed Shelf Of Up To $50 MillionSEC Filing -February 11, 2025 at 05:44 pm EST - Marketscreener.com

Feb 11, 2025
pulisher
Feb 04, 2025

Cancer Breakthrough: Vivos RadioGel Eliminates 80% of Tumor Mass in Groundbreaking Trial - Stock Titan

Feb 04, 2025
pulisher
Jan 29, 2025

Trapped in CPAP Dependency? Vivos Liberates OSA Patients with Non-Invasive Solution - PR Web

Jan 29, 2025
pulisher
Jan 25, 2025

Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders - MSN

Jan 25, 2025
pulisher
Jan 22, 2025

Vivos Therapeutics (VVOS) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025
pulisher
Jan 13, 2025

VVOS Stock Price and Chart — NASDAQ:VVOS — TradingView«Кавказ Пост» - «Кавказ Пост» - новости Северного Кавказа и Закавказья

Jan 13, 2025
pulisher
Jan 09, 2025

Best Momentum Stocks to Buy for January 8th - MSN

Jan 09, 2025
pulisher
Jan 08, 2025

Recognizing Sleep as the Sixth Vital Sign: How Vivos Is Redefining Health Care - PR Web

Jan 08, 2025
pulisher
Dec 31, 2024

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Up 28.9% in December - Defense World

Dec 31, 2024
pulisher
Dec 27, 2024

After Leaping 35% Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 27, 2024
pulisher
Dec 23, 2024

Vivos Therapeutics announces $3.5 million stock offering - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Dec 23, 2024
pulisher
Dec 23, 2024

Vivos Therapeutics Secures $3.5M Financing Through Strategic Share Offering and Warrants - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

Vivos Therapeutics announces funding boost - Proactive Investors USA

Dec 23, 2024

Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):